Finally, further research is needed to assess the factors influencing progression of NENs during pregnancy, including the hormone responsiveness of NENs and the prevalence of oestrogen and progesterone receptor expression, because in our cohort there was a suggestion that pregnancy may enhance tumour growth in these patients. This evidence concerns the gene PGR and neoplasm.